Regulus Therapeutics
RGLS
#7200
Rank
โ‚น52.34 B
Marketcap
โ‚น756.11
Share price
0.00%
Change (1 day)
460.86%
Change (1 year)

Market capitalization of Regulus Therapeutics (RGLS)

Last known market cap: โ‚น52.34 Billion

On August 27, 2025 Regulus Therapeutics had a market cap of โ‚น52.34 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Regulus Therapeutics from 2012 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น50.71 B486.08%
2024โ‚น8.65 B301.56%
2023โ‚น2.15 B12.87%
2022โ‚น1.90 B-44.22%
2021โ‚น3.42 B-45.41%
2020โ‚น6.26 B370.01%
2019โ‚น1.33 B132.49%
2018โ‚น0.57 B-91.69%
2017โ‚น6.90 B-14.69%
2016โ‚น8.09 B-73.49%
2015โ‚น30.52 B-38.66%
2014โ‚น49.75 B160.8%
2013โ‚น19.07 B54.35%
2012โ‚น12.35 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sanofi
SNY
โ‚น10.350 T 19,672.44%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
โ‚น3.418 T 6,430.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น11.137 T 21,174.84%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น25.055 T 47,763.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น8.870 T 16,845.47%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
โ‚น2.84 B-94.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
โ‚น275.91 B 427.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น1.784 T 3,309.66%๐Ÿ‡บ๐Ÿ‡ธ USA